ROCKET PHARMACEUTICALS, INC. (RCKT) › Capital ExpendituresROCKET PHARMACEUTICALS, INC. (RCKT) — Capital ExpendituresAnnual figures by fiscal year, from SEC filings.2016: $335.0K2017: $760.0K2018: $1.45M2019: $23.27M2020: $20.61M2021: $7.62M2022: $8.36M2023: $16.44M2024: $5.86M2025: $440.0K$440.0K2016Capital Expenditures (USD)2025Fiscal YearCapital ExpendituresChange YoY2025$440.0K-92.5%2024$5.86M-64.3%2023$16.44M+96.6%2022$8.36M+9.7%2021$7.62M-63.0%2020$20.61M-11.4%2019$23.27M+1501.4%2018$1.45M+91.2%2017$760.0K+126.9%2016$335.0K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per Share